Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Allogene Therapeutics, Inc. (ALLO)

Balance Sheet

Standardized | As Reported Annual | Quarterly
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
   10-K10-K10-K10-K10-K
Assets  
Cash and equivalents  61.9173.3183.4175.192.4
Short-term investments  455.4284.0644.6355.4367.0
Other current assets  11.514.017.214.08.6
Total current assets  528.8471.3845.1544.6468.0
Property, plant, and equipment, net  112.8123.0118.856.48.6
Intangibles     0.20.8
Long-term investments  72.0370.2412.2121.5262.0
Other fixed assets  9.65.85.24.60.2
Total assets  817.11,038.61,227.8717.8773.9
   
Accounts payable  13.910.310.49.312.3
Accrued expenses  17.916.1   
Short-term debt  0.00.00.00.00.0
Other current liabilities  22.721.883.923.817.1
Total current liabilities  54.548.294.333.129.5
Other liabilities  96.774.153.955.741.2
Total liabilities  151.2122.2148.288.870.7
   
Shareholders' equity   [+]665.9916.41,079.6629.0703.2
Tangible shareholders' equity  665.9916.41,079.6628.9702.4

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy